January 30, 2019
Pembrolizumab and Epacadostat in Treating Patients With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Read More
January 30, 2019
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Read More
December 10, 2018
Pembrolizumab and Epacadostat in Treating Participants With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma
Read More
December 10, 2018
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Read More
X